All Stories

  1. Insulin Receptor Family Autoantibodies in Patients with Type B insulin Resistance
  2. Selenium supplementation in individuals with newly diagnosed Graves' hyperthyroidism: A double-blind, multi-centre RCT
  3. Serum selenoprotein P concentrations and cardiovascular disease: results from a large, prospective cohort study of older German adults
  4. Monitoring copper ions in C. elegans using porphyrin phosphonic acids
  5. Trace element-linked DNA methylation sites and their association with type 2 diabetes and cardiovascular diseases: EPIC-Potsdam cohort study
  6. Vitamin A acts as a potent suppressor of selenoprotein P with potential relevance for multivitamin supplementation
  7. Associations of selenium status with all-cause and cause-specific mortality: a systematic review and meta-analysis of cohort studies
  8. PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance
  9. Editorial: Thyroid hormones and diet
  10. Dysregulation of hepatic deiodinase type I in metabolically associated steatotic liver disease
  11. Trace elements and risk of diabetes-related vascular complications: results from the EPIC-Potsdam cohort study
  12. Colorectal cancer mortality is associated with low selenoprotein P status at diagnosis
  13. Selenium and Coenzyme Q10 Supplementation and Sex Differences in Cardiovascular Mortality Results from a Prospective Randomized Double-Blind Placebo-Controlled Trial in Elderly People Low in Selenium
  14. Trace Element Deficiency in Axial Spondyloarthritis and Psoriatic Arthritis in Relation to Markers of Inflammation and Remission
  15. Low blood levels of selenium, selenoprotein P and GPx3 are associated with accelerated biological aging: results from the Berlin Aging Study II (BASE-II)
  16. Serum CD5L Responds Positively to Selenium and Coenzyme Q10 Supplementation with Relation to Thyroid Hormones, Mortality, and Health-Related Quality-of-Life—A Sub-Analysis of a Double-Blind Randomised Placebo-Controlled Trial in Elderly Low in Selenium
  17. Selenoprotein P as a prognostic biomarker of burn sepsis: A prospective cohort study
  18. Total and Free Zinc Dynamics as Biomarkers for Neurological Impairment in Traumatic Spinal Cord Injury
  19. Serum selenium, selenoprotein P and glutathione peroxidase 3 in rheumatoid, psoriatic, juvenile idiopathic arthritis, and osteoarthritis
  20. An expert consensus statement on biomarkers of ageing for use in intervention studies
  21. Circulating Glutathione Peroxidase-3 in Elderly—Association with Renal Function, Cardiovascular Mortality, and Impact of Selenium and Coenzyme Q10 Supplementation
  22. PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance
  23. A systematic review of Selenium as a complementary treatment in cancer patients
  24. Low Levels of Selenoprotein P Are Associated With Cognitive Impairment in Patients Hospitalized for Heart Failure
  25. The association between selenium status and global and attention-specific cognition in very old adults in the Newcastle 85+ Study: cross-sectional and longitudinal analyses
  26. Serum CD5L as potential biomarker of thyroid hormone status during pregnancy
  27. Change in the serum selenium level of patients with non-metastatic and metastatic non-small cell lung cancer (NSCLC) during radiotherapy as a predictive factor for survival
  28. Selenium, diabetes, and their intricate sex-specific relationship
  29. Selenoprotein P increases upon selenium and coenzyme Q10 supplementation and is associated with telomere length, quality of life and reduced inflammation and mortality
  30. New-onset autoantibodies to selenoprotein P following severe burn injury
  31. Maternal selenium deficiency during pregnancy in association with autism and ADHD traits in children: The Odense Child Cohort
  32. Detection of natural autoimmunity to ghrelin in diabetes mellitus
  33. Correspondence
  34. Identification of Human TRIAC Transmembrane Transporters
  35. Determination of copper status by five biomarkers in serum of healthy women
  36. Comment on Ambra et al. Could Selenium Supplementation Prevent COVID-19? A Comprehensive Review of Available Studies. Molecules 2023, 28, 4130
  37. Comparative investigation of selenium-enriched Pleurotus ostreatus and Ganoderma lucidum as natural sources of selenium supplementation
  38. Matrix metalloproteinase-9 deficiency confers resilience in fibrodysplasia ossificans progressiva in a man and mice
  39. Selenium supplementation and placebo are equally effective in improving quality of life in patients with hypothyroidism
  40. Strong associations of serum selenoprotein P with all-cause mortality and mortality due to cancer, cardiovascular, respiratory and gastrointestinal diseases in older German adults
  41. Association between low selenoprotein P concentrations and anaemia in hospitalized heart failure patients
  42. Identifying a target group for selenium supplementation in high-risk cardiac surgery: a secondary analysis of the SUSTAIN CSX trial
  43. Serum selenium, selenoprotein P, and glutathione peroxidase 3 during early and late pregnancy in association with gestational diabetes mellitus: Prospective Odense Child Cohort
  44. Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study
  45. Serum Selenium-Binding Protein 1 (SELENBP1) in Burn Injury: A Potential Biomarker of Disease Severity and Clinical Course
  46. Selenium status and its determinants in very old adults: insights from the Newcastle 85+ Study
  47. Combined copper and zinc deficiency is associated with reduced SARS-CoV-2 immunization response to BNT162b2 vaccination
  48. Selenoprotein P deficiency is associated with higher risk of incident heart failure
  49. Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study
  50. Are Twin Pregnancies at Higher Risk for Iron and Calcium Deficiency than Singleton Pregnancies?
  51. Sex-specific associations of serum selenium and selenoprotein P with type 2 diabetes mellitus and hypertension in the Berlin Aging Study II
  52. Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium transport impairment and acquired resistance to thyroid hormone
  53. A fluorometric assay to determine labile copper(II) ions in serum
  54. Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study
  55. Iodine deficiency and real-life supplementation ineffectiveness in Polish pregnant women and its impact on thyroid metabolism
  56. Excessive copper impairs intrahepatocyte trafficking and secretion of selenoprotein P
  57. Antibodies to SARS-CoV-2 in follicular fluids and their association with assisted reproduction
  58. Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure
  59. A Novel In Vitro Assay Correlates Insulin Receptor Autoantibodies With Fasting Insulin in Type B Insulin Resistance
  60. Detection of antibodies to SARS-CoV-2 after vaccination in seminal plasma and their association to sperm parameters
  61. Effect of High-Dose Selenium on Postoperative Organ Dysfunction and Mortality in Cardiac Surgery Patients
  62. Trace element equilibrium in acute heart failure and the effect of empagliflozin
  63. High throughput drug screening identifies resveratrol as suppressor of hepatic SELENOP expression
  64. Prediagnostic serum calcium concentrations and risk of colorectal cancer development in 2 large European prospective cohorts
  65. Fatal congenital copper transport defect caused by a homozygous likely pathogenic variant of SLC31A1
  66. Association of COVID-19 mortality with serum selenium, zinc and copper: Six observational studies across Europe
  67. Seizures, ataxia and parvalbumin-expressing interneurons respond to selenium supply in Selenop-deficient mice
  68. Selenoprotein P – Selenium transport protein, enzyme and biomarker of selenium status
  69. Selenium Status and Supplementation Effects in Pregnancy—A Study on Mother–Child Pairs from a Single-Center Cohort
  70. Assessment of the Effect of Selenium Supplementation on Production of Selected Cytokines in Women with Hashimoto’s Thyroiditis
  71. Increased Incidence of Hashimoto Thyroiditis in Selenium Deficiency: A Prospective 6-Year Cohort Study
  72. Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension
  73. Autoimmunity to selenoprotein P predicts breast cancer recurrence
  74. Serum Free Zinc Is Associated With Vaccination Response to SARS-CoV-2
  75. Selenium Status in Paediatric Patients with Neurodevelopmental Diseases
  76. Humoral immune response to COVID-19 mRNA vaccination in relation to selenium status
  77. Free Zinc as a Predictive Marker for COVID-19 Mortality Risk
  78. Editorial: Selenium and Selenoproteins in Brain Development, Function, and Disease
  79. Selenium Deficiency in COVID-19—A Possible Long-Lasting Toxic Relationship
  80. High‐dose supplementation of selenium in left ventricular assist device implant surgery: A double‐blinded, randomized controlled pilot trial
  81. Autoimmunity to the Follicle-Stimulating Hormone Receptor (FSHR) and Luteinizing Hormone Receptor (LHR) in Polycystic Ovarian Syndrome
  82. Natural Autoimmunity to Selenoprotein P Impairs Selenium Transport in Hashimoto’s Thyroiditis
  83. Insulin Receptor Autoantibody–mediated Hypoglycemia in a Woman With Mixed Connective Tissue Disease
  84. Pronounced Trace Element Variation in Follicular Fluids of Subfertile Women Undergoing Assisted Reproduction
  85. Relationship between Vitamin D Status and Antibody Response to COVID-19 mRNA Vaccination in Healthy Adults
  86. Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort study
  87. The Nutritional Supply of Iodine and Selenium Affects Thyroid Hormone Axis Related Endpoints in Mice
  88. Prediagnostic Blood Selenium Status and Mortality among Patients with Colorectal Cancer in Western European Populations
  89. Ageing-associated effects of a long-term dietary modulation of four trace elements in mice
  90. Course and Survival of COVID-19 Patients with Comorbidities in Relation to the Trace Element Status at Hospital Admission
  91. Copper Isotopes and Copper to Zinc Ratio as Possible Biomarkers for Thyroid Cancer
  92. Maternal Thyroid Hormone Programs Cardiovascular Functions in the Offspring
  93. Selenium Deficiency Due to Diet, Pregnancy, Severe Illness, or COVID-19—A Preventable Trigger for Autoimmune Disease
  94. Positive effects of selenium supplementation in women with newly diagnosed Hashimoto's thyroiditis in an area with low selenium status
  95. Clinical Significance of Micronutrient Supplementation in Critically Ill COVID-19 Patients with Severe ARDS
  96. Relation of Serum Copper Status to Survival in COVID-19
  97. Selenium-Binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury
  98. Predicting neurological recovery after traumatic spinal cord injury by time-resolved analysis of monocyte subsets
  99. Relation of Serum Copper Status to Survival in COVID-19
  100. Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
  101. Natural autoantibodies to the gonadotropin-releasing hormone receptor in polycystic ovarian syndrome
  102. Selenium supplementation to improve bone health in postmenopausal women: the SeMS three-arm RCT
  103. Effect of selenium supplementation on musculoskeletal health in older women: a randomised, double-blind, placebo-controlled trial
  104. Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
  105. Selenium Status Should Be Assessed
  106. Trace element profile and incidence of type 2 diabetes, cardiovascular disease and colorectal cancer: results from the EPIC-Potsdam cohort study
  107. Serum Selenium Status as a Diagnostic Marker for the Prognosis of Liver Transplantation
  108. PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma
  109. Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker
  110. Serum Selenium Status as Diagnostic Marker for Prognosis in Liver Transplantation
  111. Re-visiting autoimmunity to sodium-iodide symporter and pendrin in thyroid disease
  112. Se Status Prediction by Food Intake as Compared to Circulating Biomarkers in a West Algerian Population
  113. Copper interferes with selenoprotein synthesis and activity
  114. Selenium deficiency is linearly associated with hypoglycemia in healthy adults
  115. Toenail selenium, plasma selenoprotein P and risk of advanced prostate cancer: A nested case‐control study
  116. Selenium Deficiency Is Associated with Mortality Risk from COVID-19
  117. Selenium Deficiency is Associated with Mortality Risk from COVID-19
  118. Aging affects sex- and organ-specific trace element profiles in mice
  119. Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis
  120. CD5L Constitutes a Novel Biomarker for Integrated Hepatic Thyroid Hormone Action
  121. Zinc Concentration Dynamics Indicate Neurological Impairment Odds after Traumatic Spinal Cord Injury
  122. Selenoprotein P as Biomarker of Selenium Status in Clinical Trials with Therapeutic Dosages of Selenite
  123. Copper and selenium status as biomarkers of neonatal infections
  124. Cross-sectional analysis of trace element status in thyroid disease
  125. Antagonistic Autoantibodies to Insulin-Like Growth Factor-1 Receptor Associate with Poor Physical Strength
  126. Selenium and Selenoprotein P Deficiency Correlates With Complications and Adverse Outcome After Major Trauma
  127. Selenium and copper status - potential signposts for neurological remission after traumatic spinal cord injury
  128. N- and O-Acetylated 3-Iodothyronamines Have No Metabolic or Thermogenic Effects in Male Mice
  129. The other view: the trace element selenium as a micronutrient in thyroid disease, diabetes, and beyond
  130. Challenges and perspectives of selenium supplementation in Graves’ disease and orbitopathy
  131. The Role of Magnesium in the Secondary Phase After Traumatic Spinal Cord Injury. A Prospective Clinical Observer Study
  132. Unraveling the Molecular Basis for Successful Thyroid Hormone Replacement Therapy: The Need for New Thyroid Tissue- and Pathway-Specific Biomarkers
  133. You’d Better Zinc—Trace Element Homeostasis in Infection and Inflammation
  134. Selenium-Binding Protein 1 Indicates Myocardial Stress and Risk for Adverse Outcome in Cardiac Surgery
  135. A Zinpyr-1-based Fluorimetric Microassay for Free Zinc in Human Serum
  136. Selenoprotein-P Deficiency Predicts Cardiovascular Disease and Death
  137. Selenium in Cardiac Surgery
  138. Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis
  139. Association of Selenoprotein and Selenium Pathway Genotypes with Risk of Colorectal Cancer and Interaction with Selenium Status
  140. Circulating levels of selenium-binding protein 1 (SELENBP1) are associated with risk for major adverse cardiac events and death
  141. Relation of selenium status to neuro-regeneration after traumatic spinal cord injury
  142. Expression of Selenoprotein Genes and Association with Selenium Status in Colorectal Adenoma and Colorectal Cancer
  143. Whole Blood Selenium Levels and Selenium Supplementation in Patients Treated in a Family Doctor Practice in Golßen (State of Brandenburg, Germany): A Laboratory Study
  144. Role of Selenium Intake for Risk and Development of Hyperthyroidism
  145. Selenium in Radiation Oncology—15 Years of Experiences in Germany
  146. Cow Milk Consumption Increases Iodine Status in Women of Childbearing Age in a Randomized Controlled Trial
  147. In vivo Effects of Repeated Thyronamine Administration in Male C57BL/6J Mice
  148. Severe selenium deficits in pregnant women irrespective of autoimmune thyroid disease in an area with marginal selenium intake
  149. Double-Blind, Placebo-Controlled, Randomized Trial of Selenium in Graves Hyperthyroidism
  150. Aminoglycoside-driven biosynthesis of selenium-deficient Selenoprotein P
  151. Pre-diagnostic copper and zinc biomarkers and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
  152. Homozygous mutation in TXNRD1 is associated with genetic generalized epilepsy
  153. The missing link? The potential role of selenium in the development of liver cancer and significance for the general population
  154. Sex-specific and inter-individual differences in biomarkers of selenium status identified by a calibrated ELISA for selenoprotein P
  155. Copper to Zinc Ratio as Disease Biomarker in Neonates with Early-Onset Congenital Infections
  156. Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans
  157. Trace element and cytokine concentrations in patients with Fibrodysplasia Ossificans Progressiva (FOP): A case control study
  158. Dietary Selenium and Human Health
  159. A Nonradioactive DEHAL Assay for Testing Substrates, Inhibitors, and Monitoring Endogenous Activity
  160. Treatment with recombinant human bone morphogenetic protein 7 leads to a transient induction of neutralizing autoantibodies in a subset of patients
  161. Selenoprotein Gene Nomenclature
  162. Factors impacting the aminoglycoside-induced UGA stop codon readthrough in selenoprotein translation
  163. Positive correlation of thyroid hormones and serum copper in children with congenital hypothyroidism
  164. Minireview: Insights Into the Structural and Molecular Consequences of the TSH-β Mutation C105Vfs114X
  165. Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
  166. Selenium status in neonates with connatal infection
  167. Selenium Status Is Positively Associated with Bone Mineral Density in Healthy Aging European Men
  168. Association of antiepileptic drug usage, trace elements and thyroid hormone status
  169. Silychristin, a Flavonolignan Derived From the Milk Thistle, Is a Potent Inhibitor of the Thyroid Hormone Transporter MCT8
  170. Lack of Association between Selenium Status and Disease Severity and Activity in Patients with Graves' Ophthalmopathy
  171. Low Population Selenium Status Is Associated With Increased Prevalence of Thyroid Disease
  172. Regulation of Selenocysteine Content of Human Selenoprotein P by Dietary Selenium and Insertion of Cysteine in Place of Selenocysteine
  173. Chronic Kidney Disease Distinctly Affects Relationship Between Selenoprotein P Status and Serum Thyroid Hormone Parameters
  174. Lipopolysaccharide responsiveness is an independent predictor of death in patients with chronic heart failure
  175. Revised reference values for selenium intake
  176. An Improved Nonradioactive Screening Method Identifies Genistein and Xanthohumol as Potent Inhibitors of Iodothyronine Deiodinases
  177. A Nonradioactive Uptake Assay for Rapid Analysis of Thyroid Hormone Transporter Function
  178. Strong induction of iodothyronine deiodinases by chemotherapeutic selenocompounds
  179. Gene-specific regulation of hepatic selenoprotein expression by interleukin-6
  180. Association between maternal micronutrient status, oxidative stress, and common genetic variants in antioxidant enzymes at 15 weeks׳ gestation in nulliparous women who subsequently develop preeclampsia
  181. IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo
  182. Selenium status in patients with autoimmune and non-autoimmune thyroid diseases from four European countries
  183. Secisbp2 Is Essential for Embryonic Development and Enhances Selenoprotein Expression
  184. Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort
  185. Multicenter, Phase III Trial Comparing Selenium Supplementation With Observation in Gynecologic Radiation Oncology
  186. Selenoprotein P is the essential selenium transporter for bones
  187. Hypoxia reduces and redirects selenoprotein biosynthesis
  188. Selenoprotein P in seminal fluid is a novel biomarker of sperm quality
  189. Resting Energy Expenditure and the Effects of Muscle Wasting in Patients With Chronic Heart Failure: Results From the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF)
  190. Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies
  191. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study,,
  192. Serum selenium is low in newly diagnosed Graves’ disease: a population-based study
  193. Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology - a subgroup analysis of a multicenter, phase III trial
  194. Identification of thyroid hormone response elements in vivo using mice expressing a tagged thyroid hormone receptor α1
  195. Serum 25-Hydroxyvitamin D and Cancer Risk in Older Adults: Results from a Large German Prospective Cohort Study
  196. Autoantibodies to the IGF1 Receptor in Graves' Orbitopathy
  197. Bone Turnover and Bone Mineral Density Are Independently Related to Selenium Status in Healthy Euthyroid Postmenopausal Women
  198. Polymorphisms in Thioredoxin Reductase and Selenoprotein K Genes and Selenium Status Modulate Risk of Prostate Cancer
  199. Standardization of Misleading Immunoassay Based 25-Hydroxyvitamin D Levels with Liquid Chromatography Tandem-Mass Spectrometry in a Large Cohort Study
  200. Selenoprotein P Status Correlates to Cancer-Specific Mortality in Renal Cancer Patients
  201. Thyroid Function Is Maintained Despite Increased Oxidative Stress in Mice Lacking Selenoprotein Biosynthesis in Thyroid Epithelial Cells
  202. Identification of Iopanoic Acid as Substrate of Type 1 Deiodinase by a Novel Nonradioactive Iodide-Release Assay
  203. Serum copper as a novel biomarker for resistance to thyroid hormone
  204. Structure- and cell-specific effects of imidoselenocarbamates on selenoprotein expression and activity in liver cells in culture
  205. Selenium, selenoproteins and the thyroid gland: interactions in health and disease
  206. Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture
  207. Differential responses to selenomethionine supplementation by sex and genotype in healthy adults
  208. Disorders of selenium metabolism and selenoprotein function
  209. Determinants of selenium status in healthy adults
  210. Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency
  211. Ovine pulmonary adenocarcinoma as an animal model of progressive lung cancer and the impact of nutritional selenium supply
  212. Selenoprotein-P is down-regulated in prostate cancer, which results in lack of protection against oxidative damage
  213. Activation of mitochondrial energy metabolism protects against cardiac failure
  214. Effects of Selenium Status and Polymorphisms in Selenoprotein Genes on Prostate Cancer Risk in a Prospective Study of European Men
  215. Multicenter, Phase 3 Trial Comparing Selenium Supplementation With Observation in Gynecologic Radiation Oncology
  216. Thyroid Hormones Regulate Selenoprotein Expression and Selenium Status in Mice
  217. Mutation of megalin leads to urinary loss of selenoprotein P and selenium deficiency in serum, liver, kidneys and brain
  218. Selenoprotein-Related Disease in a Young Girl Caused by Nonsense Mutations in theSBP2Gene
  219. The choice of biomarkers determines the selenium status in young German vegans and vegetarians
  220. Genetics and phenomics of selenoenzymes—How to identify an impaired biosynthesis?
  221. Selenium controls the sex-specific immune response and selenoprotein expression during the acute-phase response in mice
  222. Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
  223. Opposing effects of dietary sugar and saturated fat on cardiovascular risk factors and glucose metabolism in mitochondrially impaired mice
  224. Four selenoproteins, protein biosynthesis, and Wnt signalling are particularly sensitive to limited selenium intake in mouse colon
  225. Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration
  226. Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium
  227. Serum selenium and selenoprotein P status in adult Danes – 8-year followup
  228. Selenium in Oncology: From Chemistry to Clinics
  229. Reduced Serum Selenoprotein P Concentrations in German Prostate Cancer Patients
  230. Transgenic mice expressing small interfering RNA against Gata4 point to a crucial role of Gata4 in the heart and gonads
  231. Interference of Endocrine Disrupters with Thyroid Hormone Receptor–Dependent Transactivation
  232. Selenium Supplementation Fails to Correct the Selenoprotein Synthesis Defect in Subjects with SBP2 Gene Mutations
  233. Down‐regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice
  234. On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health
  235. V2 vasopressin receptor deficiency causes changes in expression and function of renal and hypothalamic components involved in electrolyte and water homeostasis
  236. Think globally: Act locally
  237. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum
  238. Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice
  239. Effect of age on sexually dimorphic selenoprotein expression in mice
  240. Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3
  241. Neuronal and ependymal expression of selenoprotein P in the human brain
  242. Selenium-Dependent Pre- and Posttranscriptional Mechanisms Are Responsible for Sexual Dimorphic Expression of Selenoproteins in Murine Tissues
  243. Synthesis and Metabolism of Thyroid Hormones Is Preferentially Maintained in Selenium-Deficient Transgenic Mice
  244. Altered apolipoprotein A-V expression during the acute phase response is independent of plasma triglyceride levels in mice and humans
  245. Hepatic deiodinase activity is dispensable for the maintenance of normal circulating thyroid hormone levels in mice
  246. New insights into the physiological actions of selenoproteins from genetically modified mice
  247. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism
  248. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum
  249. Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply
  250. Endocrine active compounds affect thyrotropin and thyroid hormone levels in serum as well as endpoints of thyroid hormone action in liver, heart and kidney
  251. Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic
  252. The Neurobiology of Selenium: Lessons from Transgenic Mice
  253. Efficient selenium transfer from mother to offspring in selenoprotein-P-deficient mice enables dose-dependent rescue of phenotypes associated with selenium deficiency
  254. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues
  255. Effect of endotoxin on expression of TNF receptors and transport of TNF-α at the blood-brain barrier of the rat
  256. Prolactin-Releasing Peptides Do Not Stimulate Prolactin Release in vivo
  257. Expression and Hormonal Regulation of Coactivator and Corepressor Genes
  258. Regulation of the Adenohypophyseal Thyrotropin-Releasing Hormone-Degrading Ectoenzyme by Estradiol1
  259. Thyrotropin-Releasing Hormone Gene Expression by Anterior Pituitary Cells in Long-Term Cultures Is Influenced by the Culture Conditions and Cell-to-Cell Interactions1
  260. Genomic Organization and Promoter Structure of the Human EXT1 Gene
  261. Thyroid hormones rapidly and stringently regulate the messenger RNA levels of the thyrotropin-releasing hormone (TRH) receptor and the TRH-degrading ectoenzyme.
  262. Cloning of a cDNA encoding an ectoenzyme that degrades thyrotropin-releasing hormone.